Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;50(7): e5901, 2017. tab
Artículo en Inglés | LILACS | ID: biblio-951703

RESUMEN

We aimed to quantify the penetration of ciprofloxacin, ofloxacin, and moxifloxacin into the cornea and aqueous humor of cadaver eyes. A total of 60 enucleated eyes, not eligible for corneal transplantation, were divided into three groups and immersed in commercial solutions of 0.3% ciprofloxacin, 0.3% ofloxacin, or 0.5% moxifloxacin for 10 min. Whole corneas and samples of aqueous humor were then harvested and frozen, and drug concentrations analyzed by liquid chromatography tandem mass spectrometry. The mean corneal concentration of moxifloxacin was twice as high as ofloxacin, and the latter was twice as high as ciprofloxacin. The mean concentration of moxifloxacin in the aqueous humor was four times higher than the other antibiotics, and the mean concentrations of ciprofloxacin and ofloxacin were statistically similar. The amount of drug that penetrated the anterior chamber after a 10-min immersion was far below the safe limit of endothelial toxicity of each preparation. Moxifloxacin demonstrated far superior penetration into the cornea and anterior chamber of cadaver eyes compared to ciprofloxacin and ofloxacin. One should not expect endothelial toxicity with the commercial eye drops of ciprofloxacin, ofloxacin, and moxifloxacin that reach the anterior chamber through the cornea.


Asunto(s)
Humanos , Humor Acuoso/efectos de los fármacos , Ofloxacino/farmacocinética , Ciprofloxacina/farmacocinética , Córnea/efectos de los fármacos , Fluoroquinolonas/farmacocinética , Cadáver , Enucleación del Ojo , Teorema de Bayes , Moxifloxacino
2.
Indian J Exp Biol ; 2009 Jan; 47(1): 53-6
Artículo en Inglés | IMSEAR | ID: sea-56162

RESUMEN

A comparative pharmacokinetic study of enrofloxacin (5 mg/kg, sc) was conducted in probenecid-pretreated (70 mg/kg, orally 1.5 h prior to enrofloxacin administration) lactating goats to assess the effect of probenecid on the kinetics of enrofloxacin. Concentration of enrofloxacin in plasma, milk and urine was estimated by microbiological assay using Escherichia coli (ATCC 25922). Minimum detection level of enrofloxacin was 0.01 microg/ml. The plasma log concentration versus time curve showed monophasic pattern and followed one compartment open model. Plasma drug concentration was significantly higher during 1-2 h in probenecid-pretreated group. Significantly higher drug concentration in milk was noted at most of the time points, while significantly lower urine drug concentration (0.083-1 h and 5-12 h) were obtained in probenecid-pretreated group. The kinetic parameters (A, B and 3) were significantly higher, while t(1/2)beta, MRT and Vd(area) were significantly lower in probenecid-pretreated group. Probenecid pretreatment decreased the urinary excretion of enrofloxacin, whereas enhanced excretion in milk which could be useful in cases of affections of udder in goats.


Asunto(s)
Animales , Femenino , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/análisis , Fluoroquinolonas/farmacocinética , Cabras/sangre , Cabras/fisiología , Cabras/orina , Inyecciones Subcutáneas , Lactancia/efectos de los fármacos , Leche/química , Probenecid/administración & dosificación , Probenecid/farmacología
3.
Pakistan Journal of Pharmaceutical Sciences. 2006; 19 (1): 16-21
en Inglés | IMEMR | ID: emr-79978

RESUMEN

Sparfloxacin is a broad-spectrum oral fluoroquinolone antimicrobial agent with a long elimination half-life, extensively used against both Gram-positive as well as Gram-negative microorganism. Concurrent administration of antacids and sparfloxacin decreases the gastrointestinal absorption of sparfloxacin and therapeutic failure may result. The present study was designed to evaluate the influence of some antacids on the availability of sparfloxacin. The release of sparfloxacin from tablets in the presence of antacids like sodium bicarbonate, calcium hydroxide, calcium carbonate, aluminum hydroxide, magnesium hydroxide, magnesium carbonate, magnesium trisilicate and magaldrate has been studied on BP 2003 dissolution test apparatus. These studies were carried out in simulated gastric and intestinal juices for three hours at 37oC. The results confirmed that the dissolution rate of tablets was markedly retarded in the presence all of antacids studied, whereas magaldrate and calcium carbonate exhibited relatively higher adsorption capacities in simulated gastric juice and magnesium trisilicate and calcium hydroxide in simulated intestinal juice


Asunto(s)
Antiácidos/farmacología , Interacciones Farmacológicas , Fluoroquinolonas/farmacocinética , Antiácidos/farmacocinética , Adsorción
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA